Pancreatic Cancer Clinical Trials
Pancreatic Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for pancreatic Cancer. Corterve aggregates actively recruiting Pancreatic Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Pancreatic Cancer studies
- AOH1996 for the Treatment of Refractory Solid TumorsNCT05227326PHASE1City of Hope Medical CenterScottsdale, Arizona
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaNCT07562152PHASE3Immuneering CorporationPhoenix, Arizona
- Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic CancerNCT04172532PHASE1, PHASE2National Cancer Institute (NCI)Duarte, California
- Metarrestin (ML-246) in Subjects With Metastatic Solid TumorsNCT04222413PHASE1National Cancer Institute (NCI)Fairway, Kansas
- KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal CancerNCT06411691PHASE1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsBaltimore, Maryland
- Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 GeneNCT05372614PHASE1National Cancer Institute (NCI)Duarte, California
- Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic LesionsNCT07737171The University of Texas Health Science Center, HoustonHouston, Texas
- Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)NCT07252232PHASE3Revolution Medicines, Inc.Phoenix, Arizona
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsNCT06465069PHASE1Eli Lilly and CompanyDuarte, California
- ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic CancerNCT07444541PHASE1, PHASE2Anova Innovation LimitedLos Angeles, California
- A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerNCT07409272PHASE3Astellas Pharma Global Development, Inc.Tucson, Arizona
- A Study of MRG007 (ARR-217) in Patients With Advanced Solid TumorsNCT07066657PHASE1ArriVent BioPharma, Inc.Los Angeles, California
Pancreatic Cancer trials by state
Pancreatic Cancer trials by metro
Frequently asked questions
- How do I find recruiting Pancreatic Cancer clinical trials?
- Corterve aggregates actively recruiting Pancreatic Cancer studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Pancreatic Cancer clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Pancreatic Cancer clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.